JP2010022387A - Biodegradable and absorbable spring - Google Patents

Biodegradable and absorbable spring Download PDF

Info

Publication number
JP2010022387A
JP2010022387A JP2008183422A JP2008183422A JP2010022387A JP 2010022387 A JP2010022387 A JP 2010022387A JP 2008183422 A JP2008183422 A JP 2008183422A JP 2008183422 A JP2008183422 A JP 2008183422A JP 2010022387 A JP2010022387 A JP 2010022387A
Authority
JP
Japan
Prior art keywords
coil spring
spring
coil
biodegradable
biodegradable absorbable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008183422A
Other languages
Japanese (ja)
Other versions
JP5242271B2 (en
Inventor
Yasuo Shikinami
保夫 敷波
Kaoru Tsuta
薫 蔦
Yasuhiro Kawabe
康弘 川邊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takiron Co Ltd
Original Assignee
Takiron Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takiron Co Ltd filed Critical Takiron Co Ltd
Priority to JP2008183422A priority Critical patent/JP5242271B2/en
Publication of JP2010022387A publication Critical patent/JP2010022387A/en
Application granted granted Critical
Publication of JP5242271B2 publication Critical patent/JP5242271B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/44Joints for the spine, e.g. vertebrae, spinal discs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof

Abstract

<P>PROBLEM TO BE SOLVED: To provide a biodegradable and absorbable spring eliminating harmfulness to the living body and having various uses within the living body. <P>SOLUTION: The biodegradable and absorbable spring mainly includes a biodegradable and absorbable coil spring 1 made by molding a monofilament 1a of a biodegradable and absorbable polymer into a coil. The monofilament is drawn at a drawing ratio of 2-9 times to make the diameter of the monofilament between 0.1 mm and 1.2 mm. By doing so, the coil spring acquires an appropriate strength and size to fix an implant material within the living body. <P>COPYRIGHT: (C)2010,JPO&INPIT

Description

本発明は生体内分解吸収性ばねに関し、主に生体内でインプラント材料の固定などに用いられる為害性のない生体内分解吸収性ばねに関する。   The present invention relates to a biodegradable absorbable spring, and more particularly to a biodegradable absorbable spring that is not harmful because it is mainly used for fixing an implant material in a living body.

周知のように、コイルばね、板ばね、その他の一般的なばねは、バネ用鋼材で造られている。一方、機械機器や雑貨などの軽荷重用引張りバネとして、以下のような合成樹脂製のコイルばねも提案されている(特許文献1)。   As is well known, coil springs, leaf springs, and other general springs are made of spring steel. On the other hand, the following synthetic resin coil springs have been proposed as tension springs for light loads such as machinery and miscellaneous goods (Patent Document 1).

この合成樹脂製のコイルばねは、熱可塑性ポリエステルを溶融紡糸し、3倍以上の延伸倍率となるように延伸してなる直径1.2〜5.0mmのモノフィラメントを密着らせん状に賦型したものであって、3〜7のばね指数(コイルバネの平均径/モノフィラメントの直径)を有するものである。
特開昭61−48624号公報
This coil spring made of synthetic resin is formed by melt spinning a thermoplastic polyester and stretching a monofilament with a diameter of 1.2 to 5.0 mm formed into a close-contact spiral shape by stretching it to a stretching ratio of 3 times or more. And having a spring index of 3 to 7 (average diameter of coil spring / diameter of monofilament).
JP 61-48624 A

しかしながら、生体内に埋め込まれ、ばねとして所定の役目を果たし、最終的に生体内で分解、吸収されて消失する、為害性のない生体内分解吸収性ばねは未だ開発されていない。このような生体内分解吸収性ばね、例えばコイルばねが開発されると、後で詳しく述べるように、人工椎間板や骨欠損部再建用の骨充填材などのインプラント材料を該コイルばねによって椎間や骨欠損部に固定したり、腱や靱帯の端部を該コイルばねを介して関節骨に連結固定するなど、種々の有効な利用方法が考えられる。   However, a biodegradable absorbable spring that is embedded in the living body, plays a predetermined role as a spring, and eventually decomposes, absorbs and disappears in the living body has not yet been developed. When such a biodegradable absorbable spring, for example, a coil spring, is developed, as will be described in detail later, implant materials such as an artificial disc and a bone filling material for bone defect reconstruction are used by the coil spring to Various effective utilization methods such as fixing to a bone defect part or connecting and fixing an end of a tendon or a ligament to a joint bone via the coil spring are conceivable.

本発明は上記事情の下になされたもので、その解決しようとする課題は、生体内において種々の用途が見込まれる為害性のない生体内分解吸収性コイルばねその他の生体内分解吸収性ばねを提供することにある。   The present invention has been made under the above circumstances, and the problem to be solved is a biodegradable absorbable coil spring and other biodegradable absorbable springs that are not harmful because various uses are expected in vivo. It is to provide.

上記課題を解決するため、本発明に係る生体内分解吸収性ばねは、生体内分解吸収性ポリマーからなることを特徴とするものであり、その主たるものは、生体内分解吸収性ポリマーのモノフィラメントをコイル状に成形した生体内分解吸収性コイルばねである。このモノフィラメントの直径は0.1mm以上、1.2mm未満であることが好ましく、また、モノフィラメントは2〜9倍の延伸倍率で延伸されていることが好ましい。   In order to solve the above-mentioned problems, the biodegradable absorbable spring according to the present invention is characterized by comprising a biodegradable absorbable polymer, the main of which is a monofilament of the biodegradable absorbable polymer. It is a biodegradable absorbable coil spring formed into a coil shape. The diameter of the monofilament is preferably 0.1 mm or more and less than 1.2 mm, and the monofilament is preferably drawn at a draw ratio of 2 to 9 times.

生体内分解吸収性ポリマーとしては、ポリ−L−乳酸、ポリ−D,L−乳酸、L−乳酸とD,L−乳酸の共重合体、乳酸とグリコール酸の共重合体、乳酸とp−ジオキサノンの共重合体、乳酸とエチレングリコールの共重合体、乳酸とカプロラクトンの共重合体のいずれか単独又は二種以上の混合物が使用されるが、この中でも、結晶性のポリ−L−乳酸が特に好ましく使用される。   Biodegradable and absorbable polymers include poly-L-lactic acid, poly-D, L-lactic acid, a copolymer of L-lactic acid and D, L-lactic acid, a copolymer of lactic acid and glycolic acid, and lactic acid and p-. Either a dioxanone copolymer, a copolymer of lactic acid and ethylene glycol, or a copolymer of lactic acid and caprolactone is used singly or as a mixture of two or more. Among these, crystalline poly-L-lactic acid is used. Particularly preferably used.

本発明の生体内分解吸収性ばねは、その表面に生体活性なバイオセラミックス粉粒が吹き付けられていてもよいし、その表面に生体活性なバイオセラミックス粉粒を含んだ生体内分解吸収性ポリマー複合体のコーティング被膜が形成されていてもよい。   The biodegradable absorbable spring of the present invention may have bioactive bioceramics particles sprayed on its surface, or the biodegradable absorbable polymer composite containing bioactive bioceramics particles on its surface A body coating film may be formed.

本発明の生体内分解吸収性コイルばねの代表的なものは、ばね端部がインプラント材料の表面から突き出した状態でインプラント材料に埋め込まれるコイルばねであって、ばね端部がコイル長方向に押圧されるとその方向に圧縮され、押圧が解除されると元のコイル長に復元する、インプラント材料固定用の生体内分解吸収性コイルばねである。   A representative example of the biodegradable absorbable coil spring of the present invention is a coil spring embedded in an implant material with the spring end protruding from the surface of the implant material, and the spring end is pressed in the coil length direction. It is a biodegradable absorbable coil spring for immobilizing an implant material that is compressed in that direction and restored to its original coil length when the pressure is released.

本発明の生体内分解吸収性ポリマーよりなる生体内分解吸収性ばねは、生体内で種々の用途が見込まれ、特に、生体内分解吸収性ポリマーのモノフィラメントをコイル状に成形した本発明の生体内分解吸収性コイルばねは、後述するように生体内でインプラント材料を椎間や骨欠損部に固定する用途に利用され、生体内で体液と接触してコイルばねの表面からポリマーの加水分解が進行するが、コイルばねの役目を果たし終える頃まではその強度を維持し、最終的には完全に加水分解されて生体内に吸収される。従って、金属製のコイルばねを用いると仮定した場合に予測される問題、例えば、金属イオンが溶出したり、異物反応が生じたり、生体内にコイルばねが永久に残ったりする問題が全て解消されるので、極めて好都合である。   The biodegradable absorbable spring comprising the biodegradable absorbable polymer of the present invention is expected to have various uses in vivo, and in particular, the biodegradable absorbable polymer monofilament of the biodegradable absorbable polymer formed into a coil shape in the present invention. Degradable and absorbable coil springs are used to fix implant materials to intervertebral bones and bone defects in vivo as described later, and polymer hydrolysis proceeds from the surface of the coil spring in contact with body fluids in vivo. However, the strength is maintained until the role of the coil spring is completed, and finally it is completely hydrolyzed and absorbed into the living body. Therefore, all the problems that can be expected when using a metal coil spring, such as elution of metal ions, a foreign body reaction, or a coil spring permanently remaining in the living body, are all solved. Therefore, it is very convenient.

生体内で使用することを考慮すると、生体内分解吸収性ポリマーのモノフィラメントの直径は、0.1mm以上、1.2mm未満であることが好ましく、0.1mmより細いモノフィラメントで造ったコイルばねは、強度が不足し、1.2mmより太いモノフィラメントで造ったコイルばねは、コイル平均径が大きく、分解吸収に要する期間も長いので、生体内での使用には不向きである。   In consideration of use in vivo, the diameter of the monofilament of the biodegradable absorbent polymer is preferably 0.1 mm or more and less than 1.2 mm, and the coil spring made of monofilament thinner than 0.1 mm is A coil spring made of a monofilament with a thickness of less than 1.2 mm is not suitable for use in vivo because the coil average diameter is large and the period required for decomposition and absorption is long.

生体内分解吸収性ポリマーのモノフィラメントは、強靱性を高めるために2〜9倍の延伸倍率で延伸されていることが好ましい。2倍未満の延伸倍率のモノフィラメントで造ったコイルばねは、その強靱性が未延伸のモノフィラメントで造ったものと殆ど変わらず、一方、延伸倍率が9倍より大きくなると、モノフィラメントがフィブリル化し、生体組織を傷つけるなどの為害性を示す懸念が生じる。   The monofilament of biodegradable and absorbable polymer is preferably stretched at a stretch ratio of 2 to 9 times in order to enhance toughness. Coil springs made of monofilaments with a draw ratio of less than 2 times have almost the same toughness as those made with unstretched monofilaments. On the other hand, when the draw ratio is greater than 9 times, the monofilaments become fibrillated and biological tissue Concerns that indicate harm due to hurting.

生体内分解吸収性ポリマーとしては、生体内での安全性が確認されている前記の各ポリマーがいずれも好適に使用されるが、その中でも、結晶性のポリ−L−乳酸は、延伸して結晶化度を適度に高めることにより、強靱で圧縮強度や引張り強度が大きいコイルばね、強靱な板ばね、その他の強靱な生体内分解吸収性ばねを得ることができるので、特に好ましく使用される。   As the biodegradable absorbable polymer, any of the above polymers that have been confirmed to be safe in vivo is preferably used. Among them, crystalline poly-L-lactic acid is stretched. By suitably increasing the crystallinity, a coil spring, a strong leaf spring, and other strong biodegradable absorbable springs that are strong and have high compressive strength and tensile strength can be obtained.

また、表面に生体活性なバイオセラミックス粉粒が吹き付けられた生体内分解吸収性ばねは、バイオセラミックス粉粒の骨伝導能ないし骨誘導能によって、骨組織を伝導ないし誘導形成して生体骨と直接結合するため、例えば、人工椎間板や骨欠損部再建用の骨充填材などのインプラント材料を、そのようなバイオセラミックス粉粒が吹き付けられたコイルばねで椎間や骨欠損部に固定すると、極めて有効である。同様に、表面に生体活性なバイオセラミックス粉粒を含んだ生体内分解吸収性ポリマー複合体のコーティング被膜が形成された生体内分解吸収性ばねも、該複合体の生体内分解吸収性ポリマーの加水分解に伴って露出するバイオセラミックス粉粒の骨伝導能ないし骨誘導能により、骨組織が伝導ないし誘導形成されて生体骨と結合するため、同様に、上記のインプラント材料を、そのようなコーティング被膜が形成されたコイルバネで椎間や骨欠損部に固定すると、極めて有効である。   In addition, the biodegradable absorbable spring with bioactive bioceramics particles sprayed on the surface directly conducts and induces formation of bone tissue using the bioconductivity or osteoinductive ability of bioceramics particles. For bonding, for example, implant materials such as artificial discs and bone fillers for bone defect reconstruction are fixed to intervertebral or bone defects with a coil spring sprayed with such bioceramic powder particles. It is. Similarly, a biodegradable absorbable spring having a coating film of a biodegradable absorbable polymer composite containing bioactive bioceramic powder particles on the surface is also added to the hydrolyzed biodegradable absorbable polymer of the composite. Similarly, the above-mentioned implant material is coated with such a coating film because the bone tissue is conducted or induced to form due to the osteoconductivity or osteoinductive ability of the bioceramic powder particles that are exposed as a result of decomposition. It is extremely effective if it is fixed to an intervertebral space or a bone defect with a coil spring formed with.

以下、図面を参照して本発明の具体的な実施形態を詳述する。   Hereinafter, specific embodiments of the present invention will be described in detail with reference to the drawings.

図1は本発明の一実施形態に係る生体内分解吸収性コイルばねの説明図である。   FIG. 1 is an explanatory view of a biodegradable absorbable coil spring according to an embodiment of the present invention.

このコイルばね1は、生体内分解吸収性ポリマーの延伸されたモノフィラメント1aを、一定のコイル平均径を有する円筒型のコイル状に成形したものであって、具体的に説明すると、溶融紡糸した生体内分解吸収性ポリマーのモノフィラメントを、その融点より低く且つ100℃以上の温度で2〜9倍に延伸して、直径が0.1mm以上、1.2mm未満のモノフィラメント1aとし、この延伸されたモノフィラメントを、そのガラス転移温度(Tg)以上、結晶化温度(Tc)以下(例えばポリ−D,L−乳酸など非晶性で結晶化温度がない場合は100℃以下)の温度で回転芯棒に巻き付けて急冷することにより得られたコイルばねである。   This coil spring 1 is a monofilament 1a obtained by stretching a biodegradable absorbable polymer into a cylindrical coil shape having a certain average coil diameter. The monofilament of biodegradable absorbable polymer is stretched 2 to 9 times at a temperature lower than its melting point and 100 ° C. or higher to obtain a monofilament 1a having a diameter of 0.1 mm or more and less than 1.2 mm, and this stretched monofilament To a rotating core at a temperature not lower than the glass transition temperature (Tg) and not higher than the crystallization temperature (Tc) (for example, 100 ° C. or lower in the case of amorphous such as poly-D, L-lactic acid and no crystallization temperature). It is a coil spring obtained by winding and quenching rapidly.

生体内分解吸収性ポリマーとしては、生体に対して安全なポリ−L−乳酸、ポリ−D,L−乳酸、L−乳酸とD,L−乳酸の共重合体、乳酸とグリコール酸の共重合体、乳酸とp−ジオキサノンの共重合体、乳酸とエチレングリコールの共重合体、乳酸とカプロラクトンの共重合体のいずれか単独又は二種以上の混合物が使用される。これらのうち、結晶性のポリ−L−乳酸は、延伸して結晶化度を適度に高めることにより、強靱で圧縮強度や引張り強度が大きいコイルばねを得ることができるので、特に好ましく使用される。また、ポリ−L−乳酸以外のポリマーは、分解が比較的速く、弾力性があって脆くない、非晶質又は結晶と非晶の混在したポリマーであるので、圧縮強度や引張り強度があまり大きくなく、生体内で比較的短期間で分解吸収される柔軟なコイルばねの材料として好適に使用される。ポリマーの粘度平均分子量(Mv)は、コイルばねの強度や分解吸収の速さなどを考慮すると、ポリ−L−乳酸では5万〜40万程度、それ以外のものでは3万〜10万程度であることが好ましい。   Biodegradable and absorbable polymers include poly-L-lactic acid, poly-D, L-lactic acid, a copolymer of L-lactic acid and D, L-lactic acid, and a copolymer of lactic acid and glycolic acid. Any one of a polymer, a copolymer of lactic acid and p-dioxanone, a copolymer of lactic acid and ethylene glycol, and a copolymer of lactic acid and caprolactone may be used alone or as a mixture of two or more. Of these, crystalline poly-L-lactic acid is particularly preferably used because it can be stretched to obtain a coil spring having a high compressive strength and tensile strength by appropriately increasing the crystallinity. . In addition, polymers other than poly-L-lactic acid are relatively quick decomposition, are elastic and are not brittle, and are amorphous or a mixture of crystal and amorphous, so the compressive strength and tensile strength are too large. And is suitably used as a material for a flexible coil spring that can be decomposed and absorbed in a relatively short period of time in a living body. The viscosity average molecular weight (Mv) of the polymer is about 50,000 to 400,000 in the case of poly-L-lactic acid and about 30,000 to 100,000 in other cases in consideration of the strength of the coil spring and the speed of decomposition absorption. Preferably there is.

モノフィラメント1aの直径は、生体内で使用することを考慮すると、上記のように0.1mm以上、1.2mm未満とすることが好ましく、0.1mmより細くなると、コイルばねの強度が不足し、1.2mmより太くなると、インプラント材料の固定等に不向きなコイル平均径の大きいコイルばねとなり、分解吸収に要する期間も長くなるなどの不都合が生じる。モノフィラメント1aの更に好ましい直径は、0.3〜0.6mmである。   The diameter of the monofilament 1a is preferably 0.1 mm or more and less than 1.2 mm as described above in consideration of use in a living body, and if it is thinner than 0.1 mm, the strength of the coil spring is insufficient. When it becomes thicker than 1.2 mm, it becomes a coil spring having a large coil average diameter that is unsuitable for fixation of the implant material and the like, and there is a disadvantage that the period required for decomposition and absorption becomes long. A more preferable diameter of the monofilament 1a is 0.3 to 0.6 mm.

また、モノフィラメント1aの延伸倍率は、強靱性を高めるために上記のように2〜9倍とすることが好ましく、2倍未満の延伸倍率では強靱性があまり向上せず、一方、延伸倍率が9倍より大きくなると、ポリマー分子や結晶が過度に配向してフィブリル化し、生体組織を傷つけたり炎症を起こしたりする心配が生じる。モノフィラメント1aの更に好ましい延伸倍率は、3〜5倍である。   Further, the draw ratio of the monofilament 1a is preferably 2 to 9 times as described above in order to increase toughness, and the toughness is not improved so much at a draw ratio of less than 2 times, while the draw ratio is 9 If it is larger than twice, the polymer molecules and crystals are excessively oriented and fibrillated, and there is a concern that the living tissue is damaged or inflamed. The more preferable draw ratio of the monofilament 1a is 3 to 5 times.

結晶性のポリ−L−乳酸からなるモノフィラメントを延伸すると結晶化度が高くなるが、結晶化度が高くなりすぎると、硬くて脆いモノフィラメントとなり、強靱なコイルばねを得ることが困難になるので、結晶化度は75%以下にすることが好ましい。延伸倍率が上記のように9倍以下であれば、結晶化度は75%以下となる。更に好ましい結晶化度は60%以下である。   If a monofilament made of crystalline poly-L-lactic acid is stretched, the degree of crystallinity increases, but if the degree of crystallinity becomes too high, it becomes a hard and brittle monofilament, making it difficult to obtain a tough coil spring. The crystallinity is preferably 75% or less. If the draw ratio is 9 times or less as described above, the crystallinity will be 75% or less. A more preferable crystallinity is 60% or less.

コイルばね1のばね指数(コイル平均径D/モノフィラメントの直径d)は3.5〜7に設定することが好ましく、ばね指数が3.5より小さいコイルばねは、硬くなりすぎてコイル長方向に強く圧縮したり引張ったりすると折損し易くなり、また、後述するガイド用芯棒を挿通する空間を確保し難くなるという不都合が生じる。一方、ばね指数が7より大きいコイルばねは、柔らかくなりすぎて自重でコイル長方向に伸縮するという不都合があり、また、コイル平均径が大きくなりすぎるので、後述するインプラント材料を固定するのに不向きなコイルばねとなる。   The spring index (coil average diameter D / monofilament diameter d) of the coil spring 1 is preferably set to 3.5 to 7, and the coil spring having a spring index of less than 3.5 is too hard and extends in the coil length direction. If it is strongly compressed or pulled, it is easy to break, and there is a disadvantage that it is difficult to secure a space for inserting a guide core rod described later. On the other hand, a coil spring having a spring index greater than 7 has a disadvantage that it becomes too soft and expands and contracts in the coil length direction due to its own weight, and the coil average diameter becomes too large, so it is not suitable for fixing an implant material described later. Coil spring.

コイルばね1のコイルピッチPは特に限定されないが、後述するように、インプラント材料固定用の圧縮コイルばねの場合は、コイル長方向にかなり大きく圧縮、復元することが必要となるため、コイルピッチPをモノフィラメント1aの直径dの1〜3倍に設定することが好ましい。なお、腱や靱帯を連結固定する引張りコイルばねの場合は、コイルピッチPをモノフィラメント1aの直径dと同一に設定して隙間があかないようにすればよい。   The coil pitch P of the coil spring 1 is not particularly limited. However, as will be described later, in the case of a compression coil spring for fixing an implant material, the coil pitch P needs to be considerably compressed and restored in the coil length direction. Is preferably set to 1 to 3 times the diameter d of the monofilament 1a. In the case of a tension coil spring that connects and fixes tendons and ligaments, the coil pitch P may be set equal to the diameter d of the monofilament 1a so that there is no gap.

更に、この生体内分解吸収性コイルばね1の表面には、生体活性なバイオセラミックス粉粒が吹き付けられていてもよいし、生体活性なバイオセラミックス粉粒を含んだ生体内分解吸収性ポリマー複合体のコーティング被膜が形成されていてもよい。前者のコイルばねは、表面に吹き付けられたバイオセラミックス粉粒の骨伝導能ないし骨誘導能によって、骨組織をコイルばねの表面に伝導ないし誘導形成して生体骨と直接結合し、後者のコイルばねも、生体内分解吸収性ポリマー複合体の加水分解に伴って露出するバイオセラミックス粉粒の骨伝導能ないし骨誘導能によって、骨組織を伝導ないし誘導形成して生体骨と結合するため、後述するように、骨欠損部再建用の骨充填材や人工椎間板などのインプラント材料を骨欠損部や椎間に固定する場合に極めて有効である。   Further, bioactive bioceramic powder particles may be sprayed on the surface of the biodegradable absorbable coil spring 1, or the biodegradable absorbable polymer composite containing the bioactive bioceramic powder particles. The coating film may be formed. The former coil spring is formed by conducting or inductively forming bone tissue on the surface of the coil spring by the osteoconductivity or osteoinductive ability of the bioceramic powder sprayed on the surface, and directly connecting to the living bone. However, the bioceramic powder particles exposed by hydrolysis of the biodegradable and absorbable polymer composite are conducted or induced to form bone tissue and bind to living bone by the osteoconductivity or osteoinductivity. Thus, it is extremely effective in the case where an implant material such as a bone filler for reconstruction of a bone defect portion or an artificial intervertebral disc is fixed between the bone defect portion and the intervertebral portion.

バイオセラミックス粉粒の吹き付けは、例えば次の方法で行うことができる。70〜100℃に加熱された閉鎖空間にコイルばね1を設置すると共に、バイオセラミックス粉粒よりも細かい網目をもつ金属ネットの上にバイオセラミックス粉粒を載せて、コイルばね1の下側に設置する。そして、コイルばね1とバイオセラミックス粉粒が加熱された時点で、100〜130℃に加熱された空気をドライヤーを用いて吹き付ける。このようにすると、バイオセラミックス粉粒はコイルばね1の表層に突き刺さって剥脱しないように付着する。必要ならばこの操作を何度か繰り返して、付着するバイオセラミックス粉粒の量を調節する。尚、表層に突き刺さらないで単に付着しているだけのバイオセラミックス粉粒は、エタノールや水などを用いて洗い流すことで、バイオセラミックス粉粒が容易に剥脱しない状態の吹付け処理が完了する。   The spraying of the bioceramic powder particles can be performed, for example, by the following method. The coil spring 1 is installed in a closed space heated to 70 to 100 ° C., and the bioceramic powder particles are placed on a metal net having a finer mesh than the bioceramic powder particles, and installed below the coil spring 1. To do. Then, when the coil spring 1 and the bioceramic powder are heated, air heated to 100 to 130 ° C. is blown using a dryer. In this way, the bioceramic powder particles stick to the surface layer of the coil spring 1 so as not to be peeled off. If necessary, this operation is repeated several times to adjust the amount of bioceramic powder particles adhering. Note that the bioceramic powder particles that are simply stuck without being pierced to the surface layer are washed away with ethanol, water, or the like, thereby completing the spraying process in which the bioceramic powder particles are not easily detached.

バイオセラミックス粉粒としては、生体活性があり、生体内吸収性で骨組織と完全に置換され、良好な骨誘導能ないし骨伝導能と良好な生体親和性を有する、未仮焼かつ未焼成のハイドロキシアパタイト、ジカルシウムホスフェート、トリカルシウムホスフェート、テトラカルシウムホスフェート、オクタカルシウムホスフェート、カルサイト、セラバイタル、ジオプサイト、天然珊瑚等の粉粒が好ましく使用される。これらの中でも、未仮焼かつ未焼成のハイドロキシアパタイト、トリカルシウムホスフェート、オクタカルシウムホスフェートは生体活性が極めて高く、骨誘導能ないし骨伝導能に優れ、為害性が低く、短期間で生体に吸収されるので、極めて好ましく使用される。バイオセラミックス粉粒の好ましい粒径は10μm以下、更に好ましい粒径は0.1〜5μm程度であり、10μmより大きい粒径のバイオセラミックス粉粒を用いると、コイルばね1を深く傷つける心配が生じる。   Bioceramics powder is bioactive, bioresorbable, completely replaced with bone tissue, and has good osteoinductive or osteoconductive ability and good biocompatibility. Hydroxyapatite, dicalcium phosphate, tricalcium phosphate, tetracalcium phosphate, octacalcium phosphate, calcite, serabital, diopsite, smallpox and the like are preferably used. Among these, uncalcined and uncalcined hydroxyapatite, tricalcium phosphate, and octacalcium phosphate have extremely high bioactivity, excellent osteoinductive ability or osteoconductivity, low toxicity, and absorption in the living body in a short period of time. Therefore, it is very preferably used. The preferred particle diameter of the bioceramic powder particles is 10 μm or less, and the more preferable particle diameter is about 0.1 to 5 μm. If bioceramic powder particles having a particle diameter larger than 10 μm are used, the coil spring 1 may be deeply damaged.

一方、コイルばね1の表面にコーティング被膜を形成する手段としては、エタノール、ジクロロエタン(メタン)、クロロホルムなどの揮発性溶媒に生体内分解吸収性ポリマーを溶解すると共に上記バイオセラミックス粉粒を均一に混合して懸濁液を調製し、この懸濁液をコイルばね1に塗布するか、或いは、スプレー(吹き付け)するか、或いは、この懸濁液にコイルばね1を浸漬する、などの手段が採用される。生体内分解吸収性ポリマーとしては、前述したコイルばね1の生体内分解吸収性ポリマーと同じものが使用される。   On the other hand, as a means for forming a coating film on the surface of the coil spring 1, the biodegradable absorbent polymer is dissolved in a volatile solvent such as ethanol, dichloroethane (methane), or chloroform, and the bioceramic powder particles are uniformly mixed. Then, a suspension is prepared, and this suspension is applied to the coil spring 1, sprayed (sprayed), or the coil spring 1 is immersed in this suspension. Is done. As the biodegradable absorbable polymer, the same polymer as the biodegradable absorbable polymer of the coil spring 1 described above is used.

尚、バイオセラミックス粉粒の吹き付けやコーティング被膜の形成は、コイルばね1の表面全体に行ってもよいし、後述するように骨充填材や人工椎間板などのインプラント材料の表面から突き出すコイルばね1の端部1bのみに行ってもよい。   The spraying of the bioceramic powder particles and the formation of the coating film may be performed on the entire surface of the coil spring 1 or, as will be described later, the coil spring 1 protruding from the surface of an implant material such as a bone filler or an artificial disc. You may go only to the edge part 1b.

以上のような生体内分解吸収性コイルばね1は、後述するように生体内でインプラント材料の固定など種々の用途に利用され、その役目を果たし終える頃(通常、2〜3ケ月)まで本来の強度を維持するが、加水分解の進行に伴ってその後は強度を失い、1〜2年経過する頃には大部分が分解、吸収されて、最終的に消失する。従って、金属製のコイルばねのように、金属イオンが溶出したり、異物反応が生じたり、生体内にコイルばねが永久に残ったりする問題は全て解消される。   The biodegradable absorbable coil spring 1 as described above is used for various purposes such as fixation of implant materials in a living body as will be described later, and until the end of its role (usually 2 to 3 months). Although the strength is maintained, the strength is lost thereafter as the hydrolysis proceeds, and most of them are decomposed and absorbed by one to two years, and finally disappear. Therefore, all the problems that metal ions elute, foreign matter reaction occurs, and the coil spring remains permanently in the living body like a metal coil spring are solved.

上述した生体内分解吸収性コイルばね1は、コイル平均径Dが一定した円筒型コイルばねに造られているが、ばねの一端から他端に近づくほど、コイル平均径Dが徐々に大きくなる、いわゆる円錐型コイルばねに造られていてもよい。   The above-described biodegradable absorbable coil spring 1 is made of a cylindrical coil spring having a constant coil average diameter D, and the coil average diameter D gradually increases as it approaches the other end from one end of the spring. A so-called conical coil spring may be used.

次に、図2〜図5を参照して、本発明の生体内分解吸収性コイルばねの代表的な使用例について説明する。   Next, a typical use example of the biodegradable absorbable coil spring of the present invention will be described with reference to FIGS.

図2は本発明のコイルばねを設けた骨欠損部再建用の骨充填材の斜視図、図3は同骨充填材の断面図、図4は同骨充填材を治具の挟持片で挟んで骨欠損部に充填するところを示す断面図、図5は同骨充填材を骨欠損部に充填したところを示す断面図である。   FIG. 2 is a perspective view of a bone filler for bone defect reconstruction with a coil spring according to the present invention, FIG. 3 is a sectional view of the bone filler, and FIG. FIG. 5 is a cross-sectional view showing a portion where the bone defect portion is filled with the bone filling material.

この骨充填材2は、生体活性なバイオセラミックス粉粒を含んだ生体内分解吸収性ポリマーの複合多孔体からなるものであって、この複合多孔体は内部に連続気孔を有しており、複合多孔体の表面と気孔の内面にはバイオセラミックス粉粒の一部が露出している。この複合多孔体からなる骨充填材2は、図4に示すように、生体骨3の骨欠損部3aの形状にほぼ合致するブロック形状に形成されており、骨充填材2を治具4の挟持片4a,4aで挟持して骨欠損部3aに充填するときに、骨充填材2の表面と骨欠損部3aの内面との間に挟持片4a,4aの挿入可能な隙間が確保されるように、骨充填材2の上下寸法が骨欠損部3aの上下寸法より少なくとも挟持片4a,4aの厚み寸法分だけ小さくなっている。そして、この骨充填材2には、図3に示すように上下に貫通する二つの貫通孔2a,2aが穿孔されており、各貫通孔2aには本発明のコイルばね1が挿通されて、そのばね両端部1b,1bが骨充填材2の上下両面から突き出している。また、骨欠損部3aの上下の内面には、コイルばね1の両端部1b,1bが嵌まり込む凹穴3b,3bが形成されている。   The bone filler 2 is composed of a composite porous body of a biodegradable and absorbable polymer containing bioactive bioceramic powder particles, and the composite porous body has continuous pores therein, Part of the bioceramic powder particles is exposed on the surface of the porous body and the inner surface of the pores. As shown in FIG. 4, the bone filler 2 made of this composite porous body is formed in a block shape that substantially matches the shape of the bone defect 3 a of the living bone 3. When the sandwiched pieces 4a and 4a are sandwiched and filled into the bone defect portion 3a, a gap in which the sandwich pieces 4a and 4a can be inserted is secured between the surface of the bone filler 2 and the inner surface of the bone defect portion 3a. Thus, the vertical dimension of the bone filler 2 is smaller than the vertical dimension of the bone defect 3a by at least the thickness dimension of the sandwiching pieces 4a, 4a. Then, the bone filler 2 has two through holes 2a and 2a penetrating vertically as shown in FIG. 3, and the coil spring 1 of the present invention is inserted into each through hole 2a. The spring both ends 1b and 1b protrude from the upper and lower surfaces of the bone filler 2. Further, recessed holes 3b and 3b into which both end portions 1b and 1b of the coil spring 1 are fitted are formed on the upper and lower inner surfaces of the bone defect portion 3a.

このような骨充填材2は、次の要領で生体骨3の骨欠損部3aに嵌め込まれて脱落しないように充填される。まず、図4に示すように、治具4の先端の挟持片4a,4aで上下から骨充填材2のコイルばね1を圧縮して、ばね両端部1b,1bを骨充填材2の貫通孔2aに押し込みながら、骨充填材2を挟持片4a,4aで挟持する。そして、骨充填材2を挟持片4a,4aで挟持したまま生体骨3の骨欠損部3aに嵌め込み、治具4の挟持片4a,4aを引き抜いて、図5に示すように骨充填材2を骨欠損部3aに充填する。このように充填すると、コイルばね1が復元、伸張し、ばね両端部1b,1bが骨欠損部3aの上下内面の凹穴3b,3bに嵌まり込み、骨充填材2が脱落しないように骨欠損部3aに固定される。   Such a bone filler 2 is filled in the bone defect part 3a of the living bone 3 so as not to fall off in the following manner. First, as shown in FIG. 4, the coil spring 1 of the bone filler 2 is compressed from above and below by the sandwiching pieces 4 a, 4 a at the tip of the jig 4, and both ends 1 b, 1 b of the spring are made through holes of the bone filler 2. While pushing into 2a, the bone filler 2 is clamped by the clamping pieces 4a and 4a. Then, the bone filler 2 is fitted into the bone defect portion 3a of the living bone 3 while being sandwiched between the sandwiching pieces 4a and 4a, and the sandwiching pieces 4a and 4a of the jig 4 are pulled out, as shown in FIG. Is filled into the bone defect portion 3a. When filled in this manner, the coil spring 1 is restored and stretched, and both ends 1b and 1b of the spring are fitted into the recessed holes 3b and 3b on the upper and lower inner surfaces of the bone defect portion 3a, so that the bone filler 2 does not fall off. It is fixed to the defect part 3a.

この生体活性なバイオセラミックス粉粒を含んだ生体内分解吸収性ポリマーの複合多孔体からなる骨充填材2は、加水分解の進行に伴って骨組織が骨充填材2の表面および内部に誘導(伝導)形成され、骨欠損部3aの内面と骨充填材2が早期に結合すると共に、最終的には骨充填材2が骨組織と全置換して、骨欠損部3aに骨組織が再生される。そして、コイルばね1は、骨充填材2が骨欠損部3aの内面と部分的に結合し始める頃までの2〜3ケ月の間、本来の強度を維持して骨欠損部3aからの骨充填材2の脱落を防止するが、加水分解の進行に伴ってその後は強度を失い、1〜2年経過する頃には大部分が分解、吸収されて、最終的に消失する。従って、金属製のコイルばねを用いた場合に懸念される為害性の問題を全て解消することができる。   In the bone filler 2 composed of a composite porous body of biodegradable and absorbable polymer containing bioactive bioceramic powder particles, the bone tissue is guided to the surface and inside of the bone filler 2 as hydrolysis proceeds ( Conduction) is formed, and the inner surface of the bone defect portion 3a and the bone filler 2 are bonded at an early stage. Finally, the bone filler 2 is totally replaced with the bone tissue, and the bone tissue is regenerated in the bone defect portion 3a. The The coil spring 1 maintains the original strength for a period of 2 to 3 months until the bone filler 2 starts to partially join with the inner surface of the bone defect portion 3a, and the bone filling from the bone defect portion 3a. The material 2 is prevented from falling off, but as the hydrolysis proceeds, the strength is lost thereafter. Most of the material is decomposed and absorbed at the end of 1 to 2 years, and finally disappears. Therefore, since there is a concern when a metal coil spring is used, all of the harmful problems can be solved.

尚、コイルばね1の表面にバイオセラミックス粉粒が吹き付けられていたり、バイオセラミックス粉粒を含んだ生体内分解吸収性ポリマー複合体のコーティング被膜が形成されている場合は、骨組織が早期にコイルばね1の端部1bに誘導(伝導)形成されて、コイルばね1の端部も骨欠損部3aの凹穴3bと結合するため、骨充填材2がより確実に固定されることになり、また、骨組織がコイルばね1を伝導して骨充填材2の貫通孔2aの内部に形成されるため、比較的短期間で貫通孔2aに骨組織が再建されることになる。   In addition, when bioceramic powder particles are sprayed on the surface of the coil spring 1 or a coating film of biodegradable absorbable polymer composite containing bioceramic powder particles is formed, the bone tissue is prematurely coiled. Induction (conduction) is formed at the end 1b of the spring 1, and the end of the coil spring 1 is also coupled to the recessed hole 3b of the bone defect 3a, so that the bone filler 2 is more securely fixed. Further, since the bone tissue is formed inside the through hole 2a of the bone filler 2 through the coil spring 1, the bone tissue is reconstructed in the through hole 2a in a relatively short period of time.

上記の使用例は、生体活性なバイオセラミックス粉粒を含んだ生体内分解吸収性ポリマーの複合多孔体からなる骨充填材2に、本発明の生体内分解吸収性コイルばね1を、そのばね両端部1b,1bが骨充填材2の表面から突き出すように貫通させて埋め込んだものであるが、例えばハイドロキシアパタイトやトリカルシウムホスフェート等の非多孔質又は多孔質のバイオセラミックス焼結体からなる骨充填材、或いは、チタンやタンタルなどの金属多孔体からなる骨充填材に、本発明の生体内分解吸収性コイルばね1を同様に埋め込んで使用してもよいことは言うまでもない。   In the above use example, the biodegradable absorbable coil spring 1 of the present invention is applied to the bone filler 2 made of a composite porous body of biodegradable absorbable polymer containing bioactive bioceramics particles, and both ends of the spring are disposed. The parts 1b, 1b are embedded so as to protrude from the surface of the bone filler 2, but are made of a non-porous or porous bioceramic sintered body such as hydroxyapatite or tricalcium phosphate. Needless to say, the biodegradable absorbable coil spring 1 of the present invention may be similarly embedded in a material or a bone filler made of a porous metal such as titanium or tantalum.

また、前述した円錐型コイルばねを使用する場合は、骨充填材2の上下両面に凹穴を形成し、各凹穴に円錐型コイルばねを嵌め込んで、その頂部(コイル平均径が小さい方のばね端部)を骨充填材2の上下両面から突出させればよい。   Further, when using the above-described conical coil spring, concave holes are formed on the upper and lower surfaces of the bone filler 2, and conical coil springs are fitted into the respective concave holes, and the top portion (the one with the smaller average coil diameter) is formed. The spring end portion of the bone filler 2 may be protruded from both the upper and lower surfaces.

次に、図6〜図11を参照して、本発明の生体内分解吸収性コイルばねのもう一つの代表的な使用例について説明する。   Next, another typical use example of the biodegradable absorbent coil spring of the present invention will be described with reference to FIGS.

図6は本発明のコイルばねを設けた人工椎間板の斜視図、図7は椎間に設置された同人工椎間板の側面図、図8は同人工椎間板の模式断面図、図9はコイルばねの取付方の説明図、図10は同人工椎間板を挿入治具の先端の挟持片に挟んで上下から挟圧した状態を示す模式断面図、図11の(a)(b)(c)はそれぞれ同人工椎間板を挟んだ挿入治具の先端の挟持片を少し拡げた椎体間に挿入した状態、挿入治具の挟持片を抜き取って同人工椎間板を椎間で復元させた状態、同人工椎間板が上下の椎体の圧力で圧縮された状態を示す模式断面図である。   6 is a perspective view of the artificial disc provided with the coil spring of the present invention, FIG. 7 is a side view of the artificial disc placed between the vertebrae, FIG. 8 is a schematic sectional view of the artificial disc, and FIG. FIG. 10 is a schematic cross-sectional view showing a state where the artificial intervertebral disc is clamped from above and below by sandwiching the artificial intervertebral disc at the tip of the insertion jig, and FIGS. 11A, 11B, and 11C are respectively shown. A state in which the clamping piece at the tip of the insertion jig sandwiching the artificial disc is inserted between the vertebral bodies slightly expanded, a state in which the clamping piece of the insertion jig is removed and the artificial disc is restored between the vertebrae, the artificial disc It is a schematic cross section which shows the state compressed by the pressure of the upper and lower vertebral bodies.

この人工椎間板5は、図7,図11に示すように、上下の椎体6,6の間に挿入、設置される全置換型の人工椎間板であって、図6に示すように、前半分が半円形で後半分が長方形の平面形状に形成されており、本発明の2つのコイルばね1,1がこの人工椎間板5を上下(厚み方向)に貫通して、その両端部1b,1bが人工椎間板5の上下の表面から突き出している。そして、図7,図11の(c)に示すように、この人工椎間板5を上下の椎体6,6の間に挿入、設置すると、人工椎間板5の表面から突き出したコイルばね1,1の両端部が、上下の椎体6,6に予め形成された凹穴6a6aに嵌まり込み、人工椎間板5が固定されるようになっている。2つのコイルばね1,1は、図6に示すように縦並びに配置されていてもよいし、横並びに配置されていてもよい。   This artificial intervertebral disc 5 is a total replacement type intervertebral disc inserted and placed between the upper and lower vertebral bodies 6 and 6 as shown in FIGS. 7 and 11, and as shown in FIG. Are formed in a planar shape having a semicircular shape and a rectangular shape in the rear half, and the two coil springs 1 and 1 of the present invention penetrate the artificial intervertebral disc 5 vertically (thickness direction), and both end portions 1b and 1b thereof are Projecting from the upper and lower surfaces of the artificial disc 5. 7 and FIG. 11 (c), when this artificial disc 5 is inserted and installed between the upper and lower vertebral bodies 6 and 6, coil springs 1 and 1 protruding from the surface of the artificial disc 5 Both end portions are fitted into recessed holes 6a6a formed in the upper and lower vertebral bodies 6 and 6 in advance, and the artificial disc 5 is fixed. The two coil springs 1 and 1 may be arranged vertically as shown in FIG. 6, or may be arranged side by side.

この人工椎間板5は、有機繊維を三次元織組織もしくは編組織又はこれらの複合組織とした組織構造体からなるものであって、椎間板などの軟骨と同程度の機械的強度と柔軟性を有し、動的(変形)挙動がきわめて生体模倣的(バイオミメティック)なものである。この人工椎間板5を構成する組織構造体は、本出願人が既に出願した特願平6−254515号(特許第3243679号)に記載された組織構造体と同様のものであって、その幾何学的形状を次元数で表し、繊維配列の方位数を軸数で表すと、3軸以上の多軸−三次元組織よりなる構造体が好ましく採用される。   This artificial intervertebral disc 5 is composed of a tissue structure in which organic fibers are made of a three-dimensional woven tissue or a knitted tissue or a composite tissue thereof, and has mechanical strength and flexibility similar to those of cartilage such as an intervertebral disc. The dynamic (deformation) behavior is extremely biomimetic (biomimetic). The tissue structure constituting the artificial intervertebral disc 5 is similar to the tissue structure described in Japanese Patent Application No. 6-254515 (Patent No. 3243679) already filed by the present applicant, When the target shape is represented by the number of dimensions and the number of orientations of the fiber array is represented by the number of axes, a structure composed of a multi-axis-three-dimensional structure having three or more axes is preferably employed.

有機繊維としては、生体不活性な合成樹脂繊維、例えばポリエチレン、ポリプロピレン、ポリテトラフルオロエチレンなどの繊維や、有機の芯繊維を上記の生体不活性な樹脂で被覆して生体不活性とした被覆繊維などが好ましく使用される。特に、超高分子ポリエチレンの芯繊維を直鎖状の低密度ポリエチレンの被膜で被覆した直径が0.2〜0.5mm程度の被覆繊維は、強度、硬さ、弾力性、織編のしやすさ等の点で最適な繊維である。   Organic fibers include bioinert synthetic resin fibers such as polyethylene, polypropylene, polytetrafluoroethylene, etc., and coated fibers that have been made bioinert by coating organic core fibers with the above-mentioned bioinert resin. Etc. are preferably used. In particular, a coated fiber having a diameter of about 0.2 to 0.5 mm in which a core fiber of ultra high molecular weight polyethylene is coated with a linear low-density polyethylene film has strength, hardness, elasticity, and ease of weaving. It is the most suitable fiber in terms of size.

この人工椎間板5は、図8に示すように、上面側と下面側に柔軟な表層部5a,5aを有する三層構造の組織構造体に造られており、図7に示すように上下の椎体6,6の間に人工椎間板5を設置すると、柔軟な表層部5a,5aが椎体6,6の接触面の凹凸に沿うように変形して密着するようになっている。表層部5a,5aを柔軟にする手段としては、例えば3軸−三次元組織のX,Y,Z軸の糸(有機繊維)のうちZ軸の糸を細くしたり、糸の本数を減らすなどの手段が有力であり、糸をどの程度の細さにするか、或いは、糸をどの程度減らすかによって、上下の表層部5a,5aの柔軟性を自由に変えることができる。   As shown in FIG. 8, the artificial intervertebral disc 5 is formed into a three-layer tissue structure having flexible surface layers 5a and 5a on the upper surface side and the lower surface side. When the artificial intervertebral disc 5 is installed between the bodies 6 and 6, the flexible surface portions 5a and 5a are deformed so as to follow the irregularities of the contact surfaces of the vertebral bodies 6 and 6, and are brought into close contact with each other. As means for making the surface layer portions 5a and 5a flexible, for example, among the X, Y, and Z axis yarns (organic fibers) of a three-axis-three-dimensional structure, the Z-axis yarn is thinned or the number of yarns is reduced. This means is effective, and the flexibility of the upper and lower surface layers 5a, 5a can be freely changed depending on how thin the yarn is or how much the yarn is reduced.

この人工椎間板5には、本発明の2つのコイルばね1が次の要領で取付けられている。即ち、図9に示すように、有機繊維の組織構造体からなる人工椎間板5にパイプ7を突き刺して貫通させ、このパイプ7にコイルばね1を挿入した後、パイプ7のみを引き抜くことによって、コイルばね1が取付けられており、そのばね両端部1b,1bが人工椎間板5の上下の表面から突き出している。このようにコイルばね1が組織構造体よりなる人工椎間板1に貫通状態で取付けられていると、コイルばね1が組織構造体の有機繊維と絡み合って上下に移動し難いので、コイルばね1が人工椎間板5から抜け出したり、コイルばね1のいずれか一方の端部1bが人工椎間板5の表面下に没入するようなことはない。   Two coil springs 1 of the present invention are attached to the artificial disc 5 in the following manner. That is, as shown in FIG. 9, a pipe 7 is pierced and penetrated into an artificial intervertebral disc 5 made of an organic fiber tissue structure, and after inserting the coil spring 1 into the pipe 7, only the pipe 7 is pulled out, A spring 1 is attached, and both end portions 1 b and 1 b of the spring protrude from the upper and lower surfaces of the artificial disc 5. When the coil spring 1 is attached in a penetrating manner to the artificial disc 1 made of a tissue structure in this way, the coil spring 1 is entangled with the organic fibers of the tissue structure and is difficult to move up and down. There is no possibility of slipping out of the intervertebral disc 5 or immersing any one end 1b of the coil spring 1 below the surface of the artificial intervertebral disc 5.

また、この人工椎間板5の表面には、生体活性なバイオセラミックス粉粒を吹き付けたり、生体活性なバイオセラミックス粉粒を含んだ生体内分解吸収性ポリマー複合体からなるコーティング被膜を形成することによって、早期に人工椎間板5が上下の椎体6,6と結合できるようにすることが好ましい。その場合は、コイルばね1の少なくとも人工椎間板5の表面から突き出したばね端部1b,1bにも、同様にバイオセラミックス粉粒を吹き付けたり、コーティング被膜を形成したりして、早期に上下の椎体6,6と結合できるようにすることが好ましい。   In addition, by spraying bioactive bioceramic powder particles on the surface of the artificial intervertebral disc 5 or forming a coating film made of a biodegradable absorbable polymer composite containing bioactive bioceramic powder particles, It is preferable to allow the artificial intervertebral disc 5 to be coupled to the upper and lower vertebral bodies 6 and 6 at an early stage. In that case, the bioceramic powder particles are similarly sprayed on the spring end portions 1b, 1b protruding from at least the surface of the artificial disc 5 of the coil spring 1 or a coating film is formed, so that the upper and lower vertebral bodies can be formed at an early stage. It is preferable to be able to bond with 6,6.

上記のような人工椎間板5を上下の椎体6,6間に挿入、設置する場合は、まず、図10に示すように、挿入治具8の先端の挟持片8a,8aで人工椎間板5を挟んで、人工椎間板5とコイルばね1を上下から圧縮し、図11の(a)に示すように、間隔を少し拡げた上下の椎体6,6の間の所定位置に前方から挿入する。そして、挿入治具の先端のストッパー8bで人工椎間板5を抜け出さないように当止して、挿入治具の挟持片8a,8aを椎体6,6の間から抜き取り、更にストッパー8bも抜き取る。このように挟持片8a,8aとストッパー8bを抜き取ると、図11の(b)に示すように、人工椎間板5が上下に膨れて復元すると共に、コイルばね1もコイル長方向に伸張、復元して、その両端部1b,1bが上下の椎体6,6に予め形成された凹穴6a,6aに嵌まり込む。次いで、図11の(c)に示すように、上下の椎体6,6の間隔を元の間隔に戻すと、人工椎間板5の上下の柔軟な表層部5a,5aがほぼ均等に圧縮され、上下の椎体6,6の接触面の凹凸に追従して変形しながら密着すると共に、コイルばね1の両端部1b,1bが凹穴6a,6aに深く嵌まり込み、人工椎間板5は脱転や位置ずれが生じないように確実に自立固定されて椎体6,6間に設置される。そして、この人工椎間板5は椎体6,6の動きに追従しながら極めて生体模倣的(バイオミメティック)に変形して人工椎間板としての役目を果たし、表面に吹き付けられたバイオセラミックス粉粒による骨組織の誘導(伝導)形成によって早期に上下の椎体6,6と結合する。一方、コイルばね1は、人工椎間板5が上下の椎体6,6と結合する頃までは初期の強度を有するが、その後は加水分解の進行に伴って強度を失い、大部分が分解、吸収されて、最終的には消失する。尚、コイルばね1の少なくともばね端部1b,1bにバイオセラミックス粉粒が吹き付けられていたり、前述のコーティング被膜が形成されている場合は、コイルばね1の端部1b,1bも早期に上下の椎体6,6と結合する。   When the artificial disc 5 as described above is inserted and installed between the upper and lower vertebral bodies 6 and 6, first, as shown in FIG. 10, the artificial disc 5 is held by the sandwiching pieces 8a and 8a at the distal end of the insertion jig 8. The artificial intervertebral disc 5 and the coil spring 1 are compressed from above and below by being sandwiched and inserted from the front into a predetermined position between the upper and lower vertebral bodies 6 and 6 with a slightly increased interval, as shown in FIG. Then, the artificial disc 5 is stopped with the stopper 8b at the tip of the insertion jig so as not to be pulled out, the clamping pieces 8a and 8a of the insertion jig are extracted from between the vertebral bodies 6 and 6, and the stopper 8b is also extracted. When the clamping pieces 8a and 8a and the stopper 8b are removed in this way, the artificial intervertebral disc 5 is expanded and restored as shown in FIG. 11B, and the coil spring 1 is also expanded and restored in the coil length direction. Thus, both end portions 1b and 1b are fitted into recessed holes 6a and 6a formed in the upper and lower vertebral bodies 6 and 6 in advance. Next, as shown in FIG. 11 (c), when the interval between the upper and lower vertebral bodies 6, 6 is returned to the original interval, the upper and lower flexible surface portions 5a, 5a of the artificial disc 5 are compressed almost uniformly, Following the unevenness of the contact surfaces of the upper and lower vertebral bodies 6, 6 and deforming, it comes into close contact, and both end portions 1 b, 1 b of the coil spring 1 are deeply fitted into the recessed holes 6 a, 6 a, so that the artificial disc 5 falls off In other words, it is fixed between the vertebral bodies 6 and 6 so as to be surely self-supporting so as not to be displaced. The artificial intervertebral disc 5 follows the movement of the vertebral bodies 6 and 6 and deforms extremely biomimeticly to serve as an artificial intervertebral disc. Bone tissue by bioceramics particles sprayed on the surface It is connected to the upper and lower vertebral bodies 6 and 6 at an early stage by the formation (conduction) of. On the other hand, the coil spring 1 has an initial strength until the artificial intervertebral disc 5 is joined to the upper and lower vertebral bodies 6 and 6, but thereafter loses strength with the progress of hydrolysis, and most of them are decomposed and absorbed. And eventually disappear. When bioceramic powder particles are sprayed on at least the spring ends 1b and 1b of the coil spring 1 or the coating film is formed, the ends 1b and 1b of the coil spring 1 are Combines with vertebral bodies 6,6.

本発明の生体内分解吸収性コイルばねの代表的なものは、以上のように、ばね端部1bが骨充填材2や人工椎間板5などのインプラント材料の表面から突き出した状態でインプラント材料に埋め込まれるコイルばねであって、ばね端部1bが治具の挟持片によってコイル長方向に押圧されるとその方向に圧縮され、押圧が解除されると元のコイル長に復元する、インプラント材料固定用の生体内分解吸収性圧縮コイルばねである。   As described above, typical biodegradable absorbable coil springs of the present invention are embedded in an implant material in a state in which the spring end portion 1b protrudes from the surface of the implant material such as the bone filler 2 or the artificial disc 5. For fixing the implant material, the spring end 1b is compressed in the coil length direction by the clamping piece of the jig and is compressed in that direction, and is restored to the original coil length when the pressure is released. It is a biodegradable absorbable compression coil spring.

本発明の生体内分解吸収性コイルばねのもう一つ例は、移植用の腱や靱帯の端部を関節骨に連結固定するコイルばねであって、ばね端部が引っ張られるとその方向に伸張し、引張りが解除されると元のコイル長に復元する、連結固定用の生体内分解吸収性引張コイルばねである。このようなコイルばねの表面には、TGF−β(Transforming Growth Factor-b)、BMP(Bone Morphogenic Protein)、EP4(Prostanoid Receptor)、b−FGF(basic Fibroblast Growth Fctor)、PRP(platelet-rich plasma)などの生物学的骨成長因子を、単独で又は2種以上混合して塗着し、骨組織が旺盛に成長できるようにすることが好ましい。   Another example of the biodegradable absorbable coil spring of the present invention is a coil spring that connects and fixes the end of a tendon or ligament for transplantation to a joint bone, and expands in that direction when the end of the spring is pulled. And it is a biodegradable absorbable tension coil spring for connecting and fixing, which is restored to the original coil length when the tension is released. On the surface of such a coil spring, TGF-β (Transforming Growth Factor-b), BMP (Bone Morphogenic Protein), EP4 (Prostanoid Receptor), b-FGF (basic Fibroblast Growth Fctor), PRP (platelet-rich plasma). It is preferable to apply biological bone growth factors such as) alone or in combination of two or more so that the bone tissue can grow vigorously.

上述した本発明の生体内分解吸収性ばねは、いずれもコイルばねであるが、本発明はコイルばねに限定されるものではなく、板ばね、捩りばねなど、種々のばねを包含するものである。板ばねの場合は、生体内分解吸収性ポリマーを板状に溶融成形し、これを延伸した後、又は、未延伸のまま、該ポリマーのガラス転移温度(Tg)以上、結晶化温度(Tc)以下(非晶性で結晶化温度がない場合は100℃以下)の温度で所望の板ばね形状に成形して急冷することにより造ることができる。また、捩りばねの場合は、紡糸した生体内分解吸収性ポリマーのモノフィラメントを、延伸した後、又は、未延伸のまま、ガラス転移温度(Tg)以上、結晶化温度(Tc)以下(非晶性で結晶化温度がない場合は100℃以下)の温度で、所望の捩りばね形状に成形して急冷することにより造ることができる。   The biodegradable absorbable springs of the present invention described above are all coil springs, but the present invention is not limited to coil springs, and includes various springs such as leaf springs and torsion springs. . In the case of a leaf spring, the biodegradable absorbent polymer is melt-molded into a plate shape and stretched, or after being stretched, the glass transition temperature (Tg) of the polymer or higher and the crystallization temperature (Tc). It can be made by forming into a desired leaf spring shape at a temperature below (100 ° C. or lower when there is no crystallization temperature) and quenching. In the case of a torsion spring, a monofilament of a biodegradable polymer that has been spun is stretched or unstretched, and the glass transition temperature (Tg) or higher and the crystallization temperature (Tc) or lower (amorphous) If there is no crystallization temperature at 100 ° C. or lower), it can be formed by forming into a desired torsion spring shape and quenching.

次に、本発明の生体内分解吸収性コイルばねの実施例について説明する。   Next, examples of the biodegradable absorbable coil spring of the present invention will be described.

[実施例1]
粘度平均分子量39万のポリ−L−乳酸を220℃で紡糸し、更に120℃で2倍の延伸倍率で延伸して、直径が1mmのモノフィラメントを得た。この延伸されたモノフィラメントを80℃に加熱して、直径が6mmの金属製の回転芯棒に巻き付けた後、急冷して、コイル平均径(D)が7.0mm、モノフィラメントの直径(d)が1.0mm、ばね指数(D/d)が7.0、コイルピッチ(P)が1.0mmの生体内分解吸収性コイルばねを作製した。
このコイルばねを20mmのコイル長に切断し、10mm/minの定速で、10mmのコイル長となるまで圧縮したときの最高荷重を測定して圧縮強度を求めたところ、下記の表1に示すように、0.58Nであった。
また、この20mmのコイル長に切断したコイルばねを、10mm/minの定速で、40mmのコイル長となるまで引っ張ったときの最高荷重を測定して引張り強度を求めたところ、下記の表1に示すように、1.06Nであった。
[Example 1]
Poly-L-lactic acid having a viscosity average molecular weight of 390,000 was spun at 220 ° C., and further drawn at 120 ° C. at a draw ratio of 2 times to obtain a monofilament having a diameter of 1 mm. This stretched monofilament is heated to 80 ° C., wound around a metal rotating core rod having a diameter of 6 mm, and then rapidly cooled to obtain an average coil diameter (D) of 7.0 mm and a monofilament diameter (d) of A biodegradable absorbable coil spring having 1.0 mm, a spring index (D / d) of 7.0, and a coil pitch (P) of 1.0 mm was produced.
When this coil spring was cut into a coil length of 20 mm and compressed to a coil length of 10 mm at a constant speed of 10 mm / min, the maximum load was measured to obtain the compressive strength. As such, it was 0.58N.
Further, when the coil spring cut into a coil length of 20 mm was pulled at a constant speed of 10 mm / min until reaching a coil length of 40 mm, the maximum load was measured and the tensile strength was determined. As shown in FIG.

[実施例2]
実施例1で用いたポリ−L−乳酸を220℃で紡糸して、直径が1mmの未延伸のモノフィラメントを得た。このモノフィラメントを実施例1と同様に回転芯棒に巻き付けた後、急冷して、コイル平均径(D)が7.0mm、モノフィラメントの直径(d)が1.0mm、ばね指数(D/d)が7.0、コイルピッチ(P)が1.0mmの生体内分解吸収性コイルばねを作製した。
このコイルばねについて求めた圧縮強度と引張り強度を、下記の表1に示す。
[Example 2]
The poly-L-lactic acid used in Example 1 was spun at 220 ° C. to obtain an unstretched monofilament having a diameter of 1 mm. The monofilament was wound around a rotating core rod in the same manner as in Example 1 and then rapidly cooled to obtain an average coil diameter (D) of 7.0 mm, a monofilament diameter (d) of 1.0 mm, and a spring index (D / d). Was 7.0 and the coil pitch (P) was 1.0 mm.
The compression strength and tensile strength obtained for this coil spring are shown in Table 1 below.

[実施例3〜5]
延伸倍率を4倍に変更して直径が0.4mmのモノフィラメントを得、これを直径が1.0mmの回転芯棒に巻き付けた以外は、実施例1と同様にして、コイル平均径(D)が1.4mm、モノフィラメントの直径(d)が0.4mm、ばね指数(D/d)が3.5、コイルピッチ(P)が0.4mmの生体内分解吸収性コイルばねを作製した(実施例3)。
また、紡糸により直径が0.4mmの未延伸のモノフィラメントを得、これを直径が1.0mmの回転芯棒に巻き付けた以外は、実施例2と同様にして、コイル平均径(D)が1.4mm、モノフィラメントの直径(d)が0.4mm、ばね指数(D/d)が3.5、コイルピッチ(P)が0.4mmの生体内分解吸収性コイルばねを作製した(実施例4)。
更に、延伸倍率を9倍に変更して直径が0.1mmのモノフィラメントを得、これを直径が0.6mmの回転芯棒に巻き付けた以外は、実施例1と同様にして、コイル平均径(D)が0.7mm、モノフィラメントの直径(d)が0.1mm、ばね指数(D/d)が7、コイルピッチ(P)が0.1mmの生体内分解吸収性コイルばねを作製した(実施例5)。
これらのコイルばねについて求めた圧縮強度と引張り強度を、下記の表1に示す。
[Examples 3 to 5]
The coil average diameter (D) was changed in the same manner as in Example 1 except that the draw ratio was changed to 4 times to obtain a monofilament having a diameter of 0.4 mm and this was wound around a rotating core rod having a diameter of 1.0 mm. Biodegradable absorbable coil spring having a diameter of 1.4 mm, a monofilament diameter (d) of 0.4 mm, a spring index (D / d) of 3.5, and a coil pitch (P) of 0.4 mm (implementation) Example 3).
Further, an unstretched monofilament having a diameter of 0.4 mm was obtained by spinning, and the coil average diameter (D) was 1 in the same manner as in Example 2 except that this was wound around a rotating core rod having a diameter of 1.0 mm. A biodegradable absorbable coil spring having a diameter of 0.4 mm, a monofilament diameter (d) of 0.4 mm, a spring index (D / d) of 3.5, and a coil pitch (P) of 0.4 mm was prepared (Example 4). ).
Furthermore, the coil average diameter (in the same manner as in Example 1 except that the monofilament having a diameter of 0.1 mm was obtained by changing the draw ratio to 9 times and this was wound around a rotating core rod having a diameter of 0.6 mm. A biodegradable absorbable coil spring having a D) of 0.7 mm, a monofilament diameter (d) of 0.1 mm, a spring index (D / d) of 7, and a coil pitch (P) of 0.1 mm was produced (implementation) Example 5).
Table 1 below shows the compressive strength and tensile strength obtained for these coil springs.

Figure 2010022387
Figure 2010022387

この表1より、実施例1〜4のコイルばねは、生体内でインプラント材料を固定するのに適した圧縮強度を有することが分かる。特に、モノフィラメントが延伸された実施例1,3のコイルばねは、未延伸の実施例2,4のコイルばねに比べて圧縮強度も引張り強度も向上しており、このことから、延伸がコイルばねの強靱性の向上に大きく寄与することが分かる。また、実施例5のコイルばねは、モノフィラメントの直径が0.1mmと細く、圧縮強度も引張り強度も小さいが、このようなコイルばねは、例えば、生体の軟組織である腱や靱帯で、特に微細な組織体の連結固定などに利用することができる。   From Table 1, it can be seen that the coil springs of Examples 1 to 4 have a compressive strength suitable for fixing the implant material in vivo. In particular, the coil springs of Examples 1 and 3 in which the monofilament was stretched were improved in both compressive strength and tensile strength as compared with the unstretched coil springs of Examples 2 and 4. From this fact, the stretching was performed in the coil spring. It can be seen that this greatly contributes to the improvement of the toughness of the steel. In addition, the coil spring of Example 5 has a monofilament diameter as thin as 0.1 mm and a small compressive strength and tensile strength. Such a coil spring is, for example, a tendon or a ligament that is a soft tissue of a living body, and is particularly fine. It can be used for connecting and fixing various tissue bodies.

尚、10倍以上に延伸したモノフィラメントは脆く、フィブリル化しており、回転芯棒に巻き付けてコイルばねを作製しようとしても、折損して巻き付けが困難であり、コイルばねを得ることはできなかった。   Incidentally, the monofilament stretched 10 times or more was brittle and fibrillated, and even when it was intended to produce a coil spring by winding it around a rotating core rod, it was difficult to wind and could not be obtained.

本発明の一実施形態に係る生体内分解吸収性コイルばねの説明図である。It is explanatory drawing of the biodegradable absorptive coiled spring which concerns on one Embodiment of this invention. 本発明のコイルばねを設けた骨欠損部再建用の骨充填材の斜視図である。It is a perspective view of the bone filler for bone defect part reconstruction which provided the coil spring of this invention. 同骨充填材の断面図である。It is sectional drawing of the same bone filler. 同骨充填材を治具の挟持片で挟んで骨欠損部に充填するところを示す断面図である。It is sectional drawing which shows the place which pinches | interposes the bone filling material with the clamping piece of a jig | tool, and fills a bone defect part. 同骨充填材を骨欠損部に充填したところを示す断面図である。It is sectional drawing which shows the place which filled the bone defect part with the same bone filler. 本発明のコイルばねを設けた人工椎間板の斜視図である。It is a perspective view of the artificial disc provided with the coil spring of the present invention. 椎間に設置された同人工椎間板の側面図である。It is a side view of the artificial disc installed in the intervertebral space. 同人工椎間板の模式断面図である。It is a schematic cross section of the artificial disc. 同人工椎間板へのコイルばねの取付方の説明図である。It is explanatory drawing of the attachment method of the coil spring to the artificial disc. 同人工椎間板を挿入治具の先端の挟持片に挟んで上下から挟圧した状態を示す模式断面図である。FIG. 3 is a schematic cross-sectional view showing a state where the artificial intervertebral disc is clamped from above and below with a sandwiching piece at the tip of the insertion jig. (a)は同人工椎間板を挟んだ挿入治具の先端の挟持片を少し拡げた椎体間に挿入した状態、(b)は挿入治具の挟持片を抜き取って同人工椎間板を椎間で復元させた状態、(c)は同人工椎間板が上下の椎体の圧力で圧縮された状態を示す模式断面図である。(A) is a state in which the insertion piece at the tip of the insertion jig sandwiching the artificial disc is inserted between vertebral bodies, and (b) is a state in which the insertion piece is removed and the artificial disc is inserted between the vertebrae. (C) is a schematic cross-sectional view showing a state in which the artificial intervertebral disc is compressed by the pressure of the upper and lower vertebral bodies.

符号の説明Explanation of symbols

1 生体内分解吸収性コイルばね
1a モノフィラメント
1b ばね端部
2 骨充填材
2a 貫通孔
3 生体骨
3a 骨欠損部
3b 凹穴
5 人工椎間板
5a 凹穴
6 椎体
D コイル平均径
d モノフィラメントの直径
DESCRIPTION OF SYMBOLS 1 Biodegradable absorbable coil spring 1a Monofilament 1b Spring end 2 Bone filler 2a Through hole 3 Living bone 3a Bone defect 3b Recessed hole 5 Artificial intervertebral disk 5a Recessed hole 6 Vertebral body D Coil average diameter d Monofilament diameter

Claims (9)

生体内分解吸収性ポリマーよりなる生体内分解吸収性ばね。   A biodegradable absorbable spring made of a biodegradable absorbable polymer. 生体内分解吸収性ポリマーのモノフィラメントをコイル状に成形してなる生体内分解吸収性コイルばね。   A biodegradable absorbable coil spring obtained by molding a monofilament of biodegradable absorbable polymer into a coil shape. モノフィラメントの直径が0.1mm以上、1.2mm未満である請求項2に記載の生体内分解吸収性コイルばね。   The biodegradable absorbable coil spring according to claim 2, wherein the diameter of the monofilament is 0.1 mm or more and less than 1.2 mm. モノフィラメントが2〜9倍の延伸倍率で延伸されたモノフィラメントである請求項2又は請求項3に記載の生体内分解吸収性コイルばね。   The biodegradable absorbable coil spring according to claim 2 or 3, wherein the monofilament is a monofilament drawn at a draw ratio of 2 to 9 times. ばね端部がインプラント材料の表面から突き出した状態でインプラント材料に埋め込まれるコイルばねであって、ばね端部がコイル長方向に押圧されるとその方向に圧縮され、押圧が解除されると元のコイル長に復元する、インプラント材料固定用の請求項2ないし請求項4のいずれかに記載の生体内分解吸収性コイルばね。   A coil spring embedded in the implant material with the spring end protruding from the surface of the implant material. When the spring end is pressed in the coil length direction, it is compressed in that direction, and when the pressure is released, the original The biodegradable absorbable coil spring according to any one of claims 2 to 4, which is used for fixing an implant material and is restored to a coil length. 生体内分解吸収性ポリマーが、ポリ−L−乳酸、ポリ−D,L−乳酸、L−乳酸とD,L−乳酸の共重合体、乳酸とグリコール酸の共重合体、乳酸とp−ジオキサノンの共重合体、乳酸とエチレングリコールの共重合体、乳酸とカプロラクトンの共重合体のいずれか単独又は二種以上の混合物である請求項1ないし請求項5のいずれかに記載の生体内分解吸収性ばね。   Biodegradable absorbable polymer is poly-L-lactic acid, poly-D, L-lactic acid, L-lactic acid and D, L-lactic acid copolymer, lactic acid and glycolic acid copolymer, lactic acid and p-dioxanone. The biodegradable absorption according to any one of claims 1 to 5, which is any one of a copolymer of lactic acid and ethylene glycol, a copolymer of lactic acid and caprolactone, or a mixture of two or more thereof. Sex spring. 生体内分解吸収性ポリマーが結晶性のポリ−L−乳酸である請求項1ないし請求項5のいずれかに記載の生体内分解吸収性ばね。   The biodegradable absorbable spring according to any one of claims 1 to 5, wherein the biodegradable absorbable polymer is crystalline poly-L-lactic acid. 表面に生体活性なバイオセラミックス粉粒が吹き付けられている請求項1ないし請求項7のいずれかに記載の生体内分解吸収性ばね。   The biodegradable absorbable spring according to any one of claims 1 to 7, wherein bioactive bioceramic powder particles are sprayed on the surface. 表面に生体活性なバイオセラミックス粉粒を含んだ生体内分解吸収性ポリマー複合体のコーティング被膜が形成されている請求項1ないし請求項7のいずれかに記載の生体内分解吸収性ばね。   The biodegradable absorbable spring according to any one of claims 1 to 7, wherein a coating film of a biodegradable absorbable polymer composite containing bioactive bioceramic powder particles is formed on a surface.
JP2008183422A 2008-07-15 2008-07-15 Biodegradable absorbable spring Expired - Fee Related JP5242271B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008183422A JP5242271B2 (en) 2008-07-15 2008-07-15 Biodegradable absorbable spring

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008183422A JP5242271B2 (en) 2008-07-15 2008-07-15 Biodegradable absorbable spring

Publications (2)

Publication Number Publication Date
JP2010022387A true JP2010022387A (en) 2010-02-04
JP5242271B2 JP5242271B2 (en) 2013-07-24

Family

ID=41728816

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008183422A Expired - Fee Related JP5242271B2 (en) 2008-07-15 2008-07-15 Biodegradable absorbable spring

Country Status (1)

Country Link
JP (1) JP5242271B2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010046283A (en) * 2008-08-21 2010-03-04 Takiron Co Ltd Implant material having fixing reliability toward defective bone part
JP2012095815A (en) * 2010-11-01 2012-05-24 Hi-Lex Corporation Bone prosthesis
JP2013165761A (en) * 2012-02-14 2013-08-29 Hi-Lex Corporation Material for filling in bone defect
KR20200029330A (en) * 2019-04-02 2020-03-18 하명헌 Dental implant structure

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002526127A (en) * 1998-05-06 2002-08-20 コーテック・インコーポレーテッド Spinal fixation device and method using implantable device
JP2005514152A (en) * 2001-12-31 2005-05-19 エクスパンディス リミテッド Minimally invasive modular support implant device and method
JP2007519492A (en) * 2004-01-30 2007-07-19 オステオテック,インコーポレイテッド Stacked implant for spinal fusion
JP2007529277A (en) * 2004-03-15 2007-10-25 ウォーソー・オーソペディック・インコーポレーテッド System and method for stabilizing a prosthesis
JP2008104866A (en) * 2006-09-26 2008-05-08 National Institute Of Advanced Industrial & Technology Biomaterial, method of constructing the same and use thereof
JP2008517672A (en) * 2004-10-22 2008-05-29 トランス1 インコーポレイテッド Spinal motion retention assembly
JP2009507532A (en) * 2005-08-26 2009-02-26 ローゼンブラット, ピーター エル. System and method for soft tissue reconstruction
JP2009522075A (en) * 2006-01-10 2009-06-11 アクロシュターク コーポレイション ビーヴィアイ Implant for treating the inner wall of ablation cavity
JP4971440B2 (en) * 2006-06-16 2012-07-11 エーエムエス リサーチ コーポレイション Surgical implants, tools, and methods for treating pelvic disease
JP4981690B2 (en) * 2005-02-08 2012-07-25 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ System and method for percutaneous lingual plastic surgery

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002526127A (en) * 1998-05-06 2002-08-20 コーテック・インコーポレーテッド Spinal fixation device and method using implantable device
JP2005514152A (en) * 2001-12-31 2005-05-19 エクスパンディス リミテッド Minimally invasive modular support implant device and method
JP2007519492A (en) * 2004-01-30 2007-07-19 オステオテック,インコーポレイテッド Stacked implant for spinal fusion
JP2007529277A (en) * 2004-03-15 2007-10-25 ウォーソー・オーソペディック・インコーポレーテッド System and method for stabilizing a prosthesis
JP2008517672A (en) * 2004-10-22 2008-05-29 トランス1 インコーポレイテッド Spinal motion retention assembly
JP4981690B2 (en) * 2005-02-08 2012-07-25 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ System and method for percutaneous lingual plastic surgery
JP2009507532A (en) * 2005-08-26 2009-02-26 ローゼンブラット, ピーター エル. System and method for soft tissue reconstruction
JP2009522075A (en) * 2006-01-10 2009-06-11 アクロシュターク コーポレイション ビーヴィアイ Implant for treating the inner wall of ablation cavity
JP4971440B2 (en) * 2006-06-16 2012-07-11 エーエムエス リサーチ コーポレイション Surgical implants, tools, and methods for treating pelvic disease
JP2008104866A (en) * 2006-09-26 2008-05-08 National Institute Of Advanced Industrial & Technology Biomaterial, method of constructing the same and use thereof

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010046283A (en) * 2008-08-21 2010-03-04 Takiron Co Ltd Implant material having fixing reliability toward defective bone part
JP2012095815A (en) * 2010-11-01 2012-05-24 Hi-Lex Corporation Bone prosthesis
JP2013165761A (en) * 2012-02-14 2013-08-29 Hi-Lex Corporation Material for filling in bone defect
KR20200029330A (en) * 2019-04-02 2020-03-18 하명헌 Dental implant structure
KR102151344B1 (en) 2019-04-02 2020-09-02 하명헌 Dental implant structure

Also Published As

Publication number Publication date
JP5242271B2 (en) 2013-07-24

Similar Documents

Publication Publication Date Title
US6113640A (en) Reconstructive bioabsorbable joint prosthesis
EP2114473B1 (en) Tendon or ligament bioprostheses and methods of making same
US9888996B2 (en) In vivo hydraulic fixation including bio-rivets using biocompatible expandable fibers
JP3243679B2 (en) Implant material
KR100903761B1 (en) Implant material and process for producing the same
US8740987B2 (en) Tissue-derived mesh for orthopedic regeneration
CN104043151B (en) A kind of combined artificial ligament and preparation method thereof
JP2006230722A (en) Biomaterial for artificial cartilage
JP2003500162A (en) Connective tissue reconstruction implant
JP2009535101A (en) Calcium phosphate polymer composites and methods
JP2007236802A (en) Material for implant inclination
JP5242271B2 (en) Biodegradable absorbable spring
WO2009084559A1 (en) Biomaterial for artificial cartilages
CN107913435B (en) Composite type dura mater (spinal) membrane implant, preparation method and use thereof
JP7234222B2 (en) Method for producing osteoconductive fibrous article and medical implant containing such osteoconductive fibrous article
JP4170744B2 (en) Biomaterial for artificial cartilage
CA2387099C (en) Artificial dura mater
EP1272127B1 (en) Methods for production of ligament replacement constructs
WO2010116511A1 (en) Self-establishing implant material with reliable affixability
JP2008029746A (en) Interference screw for fixing tendon or ligament, and fixation set for tendon or ligament
US20190343985A1 (en) A synthetic implantable scaffold
JP2009226079A (en) Free standing implant material with fixing reliability
JP5268140B2 (en) Implant material with reliable fixation to bone defect
JP2008029680A (en) Anchor member and artificial ligament
Dutta Applications of Polymeric Green Composites in the Biomedical Field: A Review

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110427

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121128

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130123

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130319

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130403

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20160412

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 5242271

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees